Name | MEDBIOFARM, OOO |
|---|
INN | 6714011908 |
|---|
KPP | 670901001 |
|---|
OGRN | 1026700665089 |
|---|
OKPO | 44692909 |
|---|
Address | 216100, Smolenskaya Oblast', r-n Krasninskiy, pgt Krasnyy, ul Karla Marksa, d. D. 12 |
|---|
Phone | +7 (481) 262-40-02 |
|---|
Fax | 62-40-02 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | | 47.91 | Additional activity | Mail order and Internet retailers |
Registration date | 16.09.2002 |
|---|
Registering department | Mezhrayonnaya inspektsiya Ministerstva Rossiyskoy Federatsii po nalogam i sboram 6 po Smolenskoy oblasti |
|---|
|
MEDBIOFARM, OOO (Smolensk Oblast; INN 6714011908) was registered on 16 Sep 2002. The company's authorized capital as of July 1, 2012 was 10000 rub. Type of ownership of MEDBIOFARM, OOO - Limited liability companies. Form of ownership of MEDBIOFARM, OOO - Private property. Principal activities of MEDBIOFARM, OOO: retailing drugs in specialized stores (pharmacies) (47.73), mail order and internet retailers (47.91). |
Economic indicators2023
Net profit (RAS) of MEDBIOFARM, OOO dropped in 2023 by 30.51% to 5.71 million RUB from 8.22 million RUB over the same period in 2022, the company informed. Revenue decreased in the accounting period by 13.76% to 53.83 million RUB from 62.42 million RUB in 2022. 2022
Net profit (RAS) of MEDBIOFARM, OOO dropped in 2022 8.98 times to 8.22 million RUB from 73.82 million RUB over the same period in 2021, the company informed. Revenue decreased in the accounting period by 15.44% to 62.42 million RUB from 73.82 million RUB in 2021. 2021
Net profit (RAS) of MEDBIOFARM, OOO made up 0 RUB over 2021 compared to 8.12 million RUB over 2020, the company informed. Revenue decreased in the accounting period ? times to 0.00 thousand RUB from 67.09 million RUB in 2020. 2020
Net profit (RAS) of MEDBIOFARM, OOO grew over 2020 1.88 times to 8.12 million RUB from 4.33 million RUB over 2019, the company informed. Revenue increased in the accounting period by 33.59% to 67.09 million RUB from 50.22 million RUB over 2019. 2019
Net profit (RAS) of MEDBIOFARM, OOO grew over 2019 2.05 times to 4.33 million RUB from 2.11 million RUB over 2018, the company informed. Revenue decreased in the accounting period by 6.08% to 50.22 million RUB from 53.47 million RUB in 2018. 2018
Net profit (RAS) of MEDBIOFARM, OOO dropped in 2018 by 45.75% to 2.11 million RUB from 3.89 million RUB over the same period in 2017, the company informed. Revenue decreased in the accounting period by 23.68% to 53.47 million RUB from 70.06 million RUB in 2017; cost of goods sold decreased by 23.57% to 42.91 million RUB from 56.15 million RUB; sales profit fell by 42.13% to 2.49 million RUB from 4.30 million RUB. 2017
Net profit (RAS) of MEDBIOFARM, OOO dropped in 2017 by 3.66% to 4.00 million RUB from 4.16 million RUB over the same period in 2016, the company informed. Revenue decreased in the accounting period by 4.60% to 70.06 million RUB from 73.43 million RUB in 2016; cost of goods sold decreased by 5.03% to 56.15 million RUB from 59.12 million RUB; sales profit fell by 3.82% to 4.30 million RUB from 4.47 million RUB. 2016
Net profit (RAS) of MEDBIOFARM, OOO dropped in 2016 by 1.45% to 4.16 million RUB from 4.22 million RUB over the same period in 2015, the company informed. Revenue increased in the accounting period by 7.68% to 73.43 million RUB from 68.19 million RUB over 2015; cost of goods sold grew by 8.41% to 59.12 million RUB from 54.53 million RUB; sales profit fell by 1.00% to 4.47 million RUB from 4.52 million RUB. 2014
Net profit (RAS) of MEDBIOFARM, OOO dropped in 2014 by 34.01% to 3.59 million RUB from 5.43 million RUB over the same period in 2013, the company informed. Revenue decreased in the accounting period by 0.61% to 59.73 million RUB from 60.09 million RUB in 2013; cost of goods sold grew by 0.96% to 47.28 million RUB from 46.83 million RUB; sales profit fell by 31.31% to 3.86 million RUB from 5.62 million RUB. 2012
Net profit (RAS) of MEDBIOFARM, OOO dropped in 2012 by 43.52% to 1.84 million RUB from 3.25 million RUB over the same period in 2011, the company informed. Revenue increased in the accounting period by 3.61% to 58.85 million RUB from 56.81 million RUB over 2011; cost of goods sold grew by 6.39% to 52.29 million RUB from 49.15 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|